These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: IMMUNIZATION AGAINST BRUCELLA INFECTION. 10. THE RELATIVE IMMUNOGENICITY OF BRUCELLA ABORTUS STRAIN 19-BA AND BRUCELLA MELITENSIS STRAIN REV I IN CYNOMOLGUS PHILIPPINENSIS.
    Author: ELBERG SS, FAUNCE WK.
    Journal: Bull World Health Organ; 1964; 30(5):693-9. PubMed ID: 14196815.
    Abstract:
    Continuing previous studies, the authors investigated the immunogenicity of low doses of Brucella melitensis strain Rev I in Cynomolgus monkeys challenged by the respiratory route and compared the efficacy of Rev I vaccine with that of vaccine from Br. abortus strain 19-BA.Challenge with the virulent Br. melitensis strain 6015 indicated that 19-BA vaccine was considerably more effective when administered intracutaneously than subcutaneously, whereas with Rev I vaccine the difference was slight, but Rev I conferred immunity in much lower doses. It was found that a dose as low as 260 cells of Rev I led to a high degree of immunity, although there was a very pronounced delay in the bacteriological response. The authors conclude that the results obtained justify trials of the safety of Rev I vaccine for man in the low dosage effective for cynomolgi.
    [Abstract] [Full Text] [Related] [New Search]